What's new

Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Status: Authorised

Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Status: Authorised

Apr 16, 2025 - 16:09
 0
Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Status: Authorised
Human medicines European public assessment report (EPAR): Dyrupeg, pegfilgrastim, Date of authorisation: 28/03/2025, Status: Authorised
Read More

Tags:

Previous Article

PSUSA/00000027/202407

Next Article

PepsiCo, Kraft Heinz face off with shareholder activists on sustainable packaging

Related Posts

Human medicines European public assessment report (EPAR): Cejemly, sugemalimab, Date of authorisation: 24/07/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 3, 2025  0

Human medicines European public assessment report (EPAR): Siiltibcy, Mycobacterium tuberculosis derived antigens (rdESAT-6 / rCFP-10), Date of authorisation: 13/01/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 24, 2025  0

EMEA-002734-PIP01-19-M01

EMEA-002734-PIP01-19-M01

Mar 25, 2025  0